"NEON-1 and NEON-2 Continue to Shine" - H.C. Wainwright Bullish on Alpine Immune Sciences (ALPN) With Buy Rating, $21 Price Target Jun 6, 2022 06:12AM
Oppenheimer Reiterates Outperform Rating, $17 Price Target on Alpine Immune Sciences (ALPN) Jun 2, 2022 05:56AM
Oppenheimer Reiterates Outperform Rating, $17 Price Target on Alpine Immune Sciences (ALPN) Ahead of ALPN-303 First-in-Human Data May 13, 2022 06:04AM
H.C. Wainwright Reiterates Buy Rating, $21 Price Target on Alpine Immune Sciences (ALPN), "Data Firmly Justify Expliration of davoceticept" Apr 13, 2022 06:14AM
Oppenheimer Reiterates Outperform Rating, $17 Price Target on Alpine Immune Sciences (ALPN) Apr 13, 2022 05:50AM


Apr 5, 2022 06:13AM H.C. Wainwright Reiterates Buy Rating, $21 Price Target on Alpine Immune Sciences (ALPN)